Remission of Type 2 Diabetes with Very Low-Calorie Diets—A Narrative Review
Open accessThe DOI matches its Crossref record; 80 of the 80 references it cites were found in a registry or an index.
Abstract
Very low-calorie diets (VLCD) are hypocaloric dietary regimens of approximately 400–800 kcal/day that result in 20–30% reductions in body weight, sometimes in just 12–16 weeks. A body of evidence demonstrates that adherence to VLCD in adults with type 2 diabetes (T2D) can result in marked improvements to glycemic control and even full T2D remission, challenging the convention that T2D is a lifelong disease. Although these data are promising, the majority of VLCD studies have focused on weight loss and not T2D remission as a primary endpoint. Moreover, there is a wide range of VLCD protocols and definitions of T2D remission used across these hypocaloric studies. Together the large degree of heterogeneity in VLCD studies, and how T2D remission is defined, leave many gaps in knowledge to efficacy and durability of VLCD approaches for T2D remission. This narrative review examines findings from a body of data from VLCD studies that specifically sought to investigate T2D remission, and discusses the efficacy of VLCD compared to other hypocaloric approaches, and who is likely to benefit from VLCD approaches for T2D remission.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
The cited source says what the claim attributes to it.
In the citing paper
“VLCDs are very effective at achieving weight loss and significant improvement in cardiometabolic parameters in short periods [221,222], including diabetes remission”
From Lifestyle Medicine for Obesity in the Era of Highly Effective Anti-Obesity Treatment (2025) · cites this paper as [199]
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Reduction in the incidence of type 2 diabetes with lifestyle intervention or metformin
(2002) · New England Journal of Medicine · doi:10.1056/nejmoa012512 · Cited by 19,011 · cited 3×
“The 10-year Q-RISK score, a metric used to assess cardiovascular disease (CVD) risk [43], was reduced from 23% to 7% in responders from the Counterbalance study, which is consistent with a large body of data demonstrating significant reductions in CVD with weight loss and glycemic control in T2D [44,45].”
BackgroundMethodResultGlucose control and vascular complications in veterans with type 2 diabetes
Duckworth, W., Abraira, C., Moritz, T., Reda, D., Emanuele, N., Reaven, P. D., Zieve, F. J., Marks, J., Davis, S. N., Hayward, R., et al. (2009) · New England Journal of Medicine · doi:10.1056/nejmoa0808431 · Cited by 4,762 · cited 1×
“Although current standard clinical care is effective in maintaining normoglycemia in T2D [3], long-term studies show that intensive glycemic control is not sufficient in halting T2D progression and decline in pancreatic β-cell function, or in mitigating the risk of cardiovascular disease [4,5].”
BackgroundFuller, N. R., Colagiuri, S., Schofield, D., Olson, A. D., Shrestha, R., Holzapfel, C., Wolfenstetter, S. B., Holle, R., Ahern, A. L., Hauner, H., et al. (2013) · International Journal of Obesity · doi:10.1038/ijo.2012.139 · Cited by 2,117
Lean, M. E., Leslie, W. S., Barnes, A. C., Brosnahan, N., Thom, G., McCombie, L., Peters, C., Zhyzhneuskaya, S., Al-Mrabeh, A., Hollingsworth, K. G., et al. (2018) · The Lancet · doi:10.1016/s0140-6736(17)33102-1 · Cited by 2,095 · cited 9×
“DiRECT recruited 306 overweight and obese adults aged 20–65 with a BMI range of 27–45 kg/m, diagnosed with T2D within the past 6 years [22].”
BackgroundMethodResultInfluentialWeyer, C., Bogardus, C., Mott, D. M., & Pratley, R. E. (1999) · Journal of Clinical Investigation · doi:10.1172/jci7231 · Cited by 1,940 · cited 1×
“Evidence suggesting that disease duration and β-cell function are predictors of T2D remission is consistent with the pathophysiology of T2D, in which the onset of pancreatic β-cell loss and secretory insufficiency represent a key clinical transition from insulin resistance to T2D [59].”
ResultReduction in Weight and Cardiovascular Disease Risk Factors in Individuals With Type 2 Diabetes
The Look AHEAD Research Group (2007) · Diabetes Care · doi:10.2337/dc07-0048 · Cited by 1,522
Long-term weight-loss maintenance: a meta-analysis of US studies
Anderson, J. W., Konz, E. C., Frederich, R. C., & Wood, C. L. (2001) · The American Journal of Clinical Nutrition · doi:10.1093/ajcn/74.5.579 · Cited by 1,351 · cited 2×
“The attrition rate for the DiRECT intervention group was 25% at 12 months [22], which is superior to the 25–50% dropout rates in the first 3 to 6 months of prior VLCD studies [27,46,47].”
BackgroundResultBenefits and Risks of Bariatric Surgery in Adults: A Review
Arterburn, D. E., Telem, D. A., Kushner, R. F., & Courcoulas, A. P. (2020) · JAMA · doi:10.1001/jama.2020.12567 · Cited by 1,251 · cited 1×
“Disadvantages of bariatric surgery include the risk of surgical and post-surgical complications, such as wound infection and thromboembolism [68,69], and significant financial burden, with a mean cost of $14,389 in the U.”
BackgroundLim, E. L., Hollingsworth, K. G., Aribisala, B. S., Chen, M. J., Mathers, J. C., & Taylor, R. (2011) · Diabetologia · doi:10.1007/s00125-011-2204-7 · Cited by 1,164 · cited 11×
“The normalization of FPG to non-diabetic levels after just 7 days occurred with a modest weight loss of approximately 4% of initial body weight, but a 30% decrease in ectopic pancreatic and hepatic triglyceride [17].”
BackgroundMethodResultInfluential(2010) · Archives of Internal Medicine · doi:10.1001/archinternmed.2010.334 · Cited by 1,162 · cited 2×
“[52], demonstrated in obese subjects with T2D, that euglycemia and improved insulin sensitivity can be achieved with a modest energy restriction of ~1200 kcal/day for 7 weeks [50].”
BackgroundLean, M. E. J., Leslie, W. S., Barnes, A. C., Brosnahan, N., Thom, G., McCombie, L., Peters, C., Zhyzhneuskaya, S., Al-Mrabeh, A., Hollingsworth, K. G., et al. (2019) · The Lancet Diabetes & Endocrinology · doi:10.1016/s2213-8587(19)30068-3 · Cited by 1,017 · cited 10×
“The VLCD intervention arm involved 3 phases: 1) Total diet replacement phase: a daily liquid formula diet replacement providing 825–853 kcal/day for 3–5 months (duration based on individualized weight loss goals); followed by 2) Food reintroduction phase: a stepped food reintroduction and increase in daily kcal for 6–…”
BackgroundMethodResultInfluentialRubino, F., Nathan, D. M., Eckel, R. H., Schauer, P. R., Alberti, K. G. M. M., Zimmet, P. Z., Del Prato, S., Ji, L., Sadikot, S. M., Herman, W. H., et al. (2016) · Diabetes Care · doi:10.2337/dc16-0236 · Cited by 1,008
How do we define cure of diabetes?
Buse, J. B., Caprio, S., Cefalu, W. T., Ceriello, A., Del Prato, S., Inzucchi, S. E., McLaughlin, S., Phillips, G. L., Robertson, R. P., Rubino, F., et al. (2009) · Diabetes Care · doi:10.2337/dc09-9036 · Cited by 1,003
Petersen, K. F., Dufour, S., Befroy, D., Lehrke, M., Hendler, R. E., & Shulman, G. I. (2005) · Diabetes · doi:10.2337/diabetes.54.3.603 · Cited by 911
Skyler, J. S., Bergenstal, R., Bonow, R. O., Buse, J., Deedwania, P., Gale, E. A. M., Howard, B. V., Kirkman, M. S., Kosiborod, M., Reaven, P., et al. (2009) · Diabetes Care · doi:10.2337/dc08-9026 · Cited by 881
Eight-year weight losses with an intensive lifestyle intervention: The look AHEAD study
The Look AHEAD Research Group (2014) · Obesity · doi:10.1002/oby.20662 · Cited by 842
Systematic Review: An Evaluation of Major Commercial Weight Loss Programs in the United States
Tsai, A. G., & Wadden, T. A. (2005) · Annals of Internal Medicine · doi:10.7326/0003-4819-142-1-200501040-00012 · Cited by 815 · cited 1×
“The attrition rate for the DiRECT intervention group was 25% at 12 months [22], which is superior to the 25–50% dropout rates in the first 3 to 6 months of prior VLCD studies [27,46,47].”
ResultAssociation of an intensive lifestyle intervention with remission of type 2 diabetes
Gregg, E. W., Chen, H., Wagenknecht, L. E., Clark, J. M., Delahanty, L. M., Bantle, J., Pownall, H. J., Johnson, K. C., Safford, M. M., Kitabchi, A. E., et al. (2012) · JAMA · doi:10.1001/jama.2012.67929 · Cited by 752 · cited 9×
“01) association between T2D remission across all tertiles of weight loss in the ILI group [10].”
BackgroundMethodResultInfluentialFranz, M. J., Boucher, J. L., Rutten-Ramos, S., & VanWormer, J. J. (2015) · Journal of the Academy of Nutrition and Dietetics · doi:10.1016/j.jand.2015.02.031 · Cited by 672 · cited 1×
“Weight loss is the primary approach for nutritional management of T2D [6,7], and evidence shows that, compared to standard care, intensive multicomponent lifestyle interventions, including behavior change, physical activity and dietary energy restriction produce superior weight loss and improvement to glycemic control…”
BackgroundDiabetes 2030: Insights from Yesterday, Today, and Future Trends
Rowley, W. R., Bezold, C., Arikan, Y., Byrne, E., & Krohe, S. (2017) · Population Health Management · doi:10.1089/pop.2015.0181 · Cited by 655 · cited 1×
“Type 2 diabetes (T2D) and its comorbidities have reached epidemic proportions globally [1], largely driven by high rates of obesity in adults and children.”
BackgroundRoizen, M. F. (2011) · Yearbook of Anesthesiology and Pain Management · doi:10.1016/j.yane.2011.01.029 · Cited by 487
Skyler, J. S., Bergenstal, R., Bonow, R. O., Buse, J., Deedwania, P., Gale, E. A. M., Howard, B. V., Kirkman, M. S., Kosiborod, M., Reaven, P., et al. (2009) · Journal of the American College of Cardiology · doi:10.1016/j.jacc.2008.10.008 · Cited by 471
Taylor, R., Al-Mrabeh, A., Zhyzhneuskaya, S., Peters, C., Barnes, A. C., Aribisala, B. S., Hollingsworth, K. G., Mathers, J. C., Sattar, N., & Lean, M. E. J. (2018) · Cell Metabolism · doi:10.1016/j.cmet.2018.07.003 · Cited by 450
Arterburn, D. E., Bogart, A., Sherwood, N. E., Sidney, S., Coleman, K. J., Haneuse, S., O’Connor, P. J., Theis, M. K., Campos, G. M., McCulloch, D., et al. (2013) · Obesity Surgery · doi:10.1007/s11695-012-0802-1 · Cited by 426 · cited 4×
“Complete T2D remission after 2 years was reported in approximately 55% of subjects [66].”
BackgroundInfluentialSteven, S., Hollingsworth, K. G., Al-Mrabeh, A., Avery, L., Aribisala, B., Caslake, M., & Taylor, R. (2016) · Diabetes Care · doi:10.2337/dc15-1942 · Cited by 418 · cited 10×
“[21] sought to examine the effects VLCD in subjects with relatively longer T2D disease duration.”
BackgroundResultInfluentialTaheri, S., Zaghloul, H., Chagoury, O., Elhadad, S., Ahmed, S. H., El Khatib, N., Amona, R. A., El Nahas, K., Suleiman, N., Alnaama, A., et al. (2020) · The Lancet Diabetes & Endocrinology · doi:10.1016/s2213-8587(20)30117-0 · Cited by 393 · cited 9×
“7% (<39 mmol/mol), with no antidiabetic medications for at least 3 months [25].”
BackgroundMethodResultInfluentialThe Evolution of Very‐Low‐Calorie Diets: An Update and Meta‐analysis
Tsai, A. G., & Wadden, T. A. (2006) · Obesity · doi:10.1038/oby.2006.146 · Cited by 371 · cited 2×
“Together, these data show that with VLCD, short-term onset of T2D remission can occur with even negligible weight loss, and for some individuals, modest reductions in body weight of 10–15% that have been documented in numerous VLCD studies [27,38], are sufficient for maintaining T2D remission in the long-term.”
BackgroundPathogenesis of type 2 diabetes: tracing the reverse route from cure to cause
Taylor, R. (2008) · Diabetologia · doi:10.1007/s00125-008-1116-7 · Cited by 352 · cited 2×
“The Twin Cycle hypothesis purports that in obesity and pre-diabetes, fatty liver and hepatic overproduction of triglyceride-rich very-low density lipoprotein (VLDL) has a spillover effect, leading to ectopic pancreatic fat accumulation, impaired β-cell function and onset of T2D [42].”
BackgroundWadden, T. A., Foster, G. D., & Letizia, K. A. (1994) · Journal of Consulting and Clinical Psychology · doi:10.1037//0022-006x.62.1.165 · Cited by 351 · cited 1×
“The specific use of VLCD as a protocol for T2D remission is recent and relatively unexplored, as the majority of VLCD studies to date have focused on weight loss [27,30,37,38].”
BackgroundSkyler, J. S., Bergenstal, R., Bonow, R. O., Buse, J., Deedwania, P., Gale, E. A. M., Howard, B. V., Kirkman, M. S., Kosiborod, M., Reaven, P., et al. (2009) · Circulation · doi:10.1161/circulationaha.108.191305 · Cited by 348
American Diabetes Association (2020) · Diabetes Care · doi:10.2337/dc20-s005 · Cited by 339
Associations between body mass index and the prevalence of low micronutrient levels among US adults.
Kimmons, J. E., Blanck, H. M., Tohill, B. C., Zhang, J., & Khan, L. K. (2006) · PubMed · Cited by 294
Jackness, C., Karmally, W., Febres, G., Conwell, I. M., Ahmed, L., Bessler, M., McMahon, D. J., & Korner, J. (2013) · Diabetes · doi:10.2337/db12-1762 · Cited by 267
Isbell, J. M., Tamboli, R. A., Hansen, E. N., Saliba, J., Dunn, J. P., Phillips, S. E., Marks-Shulman, P. A., & Abumrad, N. N. (2010) · Diabetes Care · doi:10.2337/dc09-2107 · Cited by 248
Van Nieuwenhove, Y. (2011) · Archives of Surgery · doi:10.1001/archsurg.2011.273 · Cited by 245 · cited 1×
“A VLCD is also commonly used 2–3 weeks prior to bariatric surgery to reduce visceral and liver fat mass, thereby minimizing peri- and post-surgical complications [72].”
BackgroundHENRY, R. R., SCHEAFFER, L., & OLEFSKY, J. M. (1985) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jcem-61-5-917 · Cited by 245 · cited 4×
“Data from DiRECT and a number of these VLCD studies also show that subjects with a relatively shorter duration of T2D and better pancreatic β-cell function, are more likely to achieve T2D remission [10,15,21,54].”
BackgroundResultInfluentialJohansson, K., Neovius, M., & Hemmingsson, E. (2014) · The American Journal of Clinical Nutrition · doi:10.3945/ajcn.113.070052 · Cited by 243
Effects of a very-low-calorie diet on long-term glycemic control in obese type 2 diabetic subjects
Wing, R. R. (1991) · Archives of Internal Medicine · doi:10.1001/archinte.1991.00400070100012 · Cited by 234
Atkinson, R. L. (1993) · JAMA: The Journal of the American Medical Association · doi:10.1001/jama.1993.03510080071034 · Cited by 230
Esposito, K., Maiorino, M. I., Petrizzo, M., Bellastella, G., & Giugliano, D. (2014) · Diabetes Care · doi:10.2337/dc13-2899 · Cited by 205
Collins, G. S., & Altman, D. G. (2009) · BMJ · doi:10.1136/bmj.b2584 · Cited by 190 · cited 1×
“The 10-year Q-RISK score, a metric used to assess cardiovascular disease (CVD) risk [43], was reduced from 23% to 7% in responders from the Counterbalance study, which is consistent with a large body of data demonstrating significant reductions in CVD with weight loss and glycemic control in T2D [44,45].”
ResultHughes, T. A., Gwynne, J. T., Switzer, B. R., Herbst, C., & White, G. (1984) · The American Journal of Medicine · doi:10.1016/0002-9343(84)90429-7 · Cited by 186
Yu, J., Zhou, X., Li, L., Li, S., Tan, J., Li, Y., & Sun, X. (2015) · Obesity Surgery · doi:10.1007/s11695-014-1460-2 · Cited by 178 · cited 2×
“6% of subjects between 2–5 years post-operatively [67].”
BackgroundGastrointestinal Complications After Bariatric Surgery.
Ma, I. T., & Ja, M. (2015) · PubMed · Cited by 170
Hepatic Lipoprotein Export and Remission of Human Type 2 Diabetes after Weight Loss
Al-Mrabeh, A., Zhyzhneuskaya, S. V., Peters, C., Barnes, A. C., Melhem, S., Jesuthasan, A., Aribisala, B., Hollingsworth, K. G., Lietz, G., Mathers, J. C., et al. (2020) · Cell Metabolism · doi:10.1016/j.cmet.2019.11.018 · Cited by 162
Micronutrient deficiency in obese subjects undergoing low calorie diet
Damms-Machado, A., Weser, G., & Bischoff, S. C. (2012) · Nutrition Journal · doi:10.1186/1475-2891-11-34 · Cited by 157
Very‐Low‐Calorie Diets and Sustained Weight Loss
Saris, W. H. M. (2001) · Obesity Research · doi:10.1038/oby.2001.134 · Cited by 153
American Diabetes Association (2020) · Diabetes Care · doi:10.2337/dc20-s008 · Cited by 148
SAVAGE, P. J., BENNION, L. J., FLOCK, E. V., NAGULESPARAN, M., MOTT, D., ROTH, J., UNGER, R. H., & BENNETT, P. H. (1979) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jcem-48-6-999 · Cited by 139
Malandrucco, I., Pasqualetti, P., Giordani, I., Manfellotto, D., Marco, F. D., Alegiani, F., Sidoti, A. M., Picconi, F., Flaviani, A. D., Frajese, G., et al. (2012) · American Journal of Clinical Nutrition · doi:10.3945/ajcn.111.023697 · Cited by 132 · cited 1×
“However, data show that various degrees of T2D remission can occur across a wide range of weight loss, sometimes before any appreciable reduction in body weight occurs [10,15,18,20,23].”
BackgroundIncidence of Remission in Adults With Type 2 Diabetes: The Diabetes & Aging Study
Karter, A. J., Nundy, S., Parker, M. M., Moffet, H. H., & Huang, E. S. (2014) · Diabetes Care · doi:10.2337/dc14-0874 · Cited by 132 · cited 1×
“With less than 2% of cases of T2D entering spontaneous remission [2], the current clinical paradigm is that T2D is irreversible.”
BackgroundSteven, S., & Taylor, R. (2015) · Diabetic Medicine · doi:10.1111/dme.12722 · Cited by 122 · cited 3×
“This small study found, similar to the Counterpoint and Counterbalance studies [17,20,21], that improvement in glycemic control was apparent in the first 7 days of onset of the VLCD and that duration of T2D was a predictor of remission (mean duration of 2 years vs.”
BackgroundResultParretti, H. M., Jebb, S. A., Johns, D. J., Lewis, A. L., Christian‐Brown, A. M., & Aveyard, P. (2016) · Obesity Reviews · doi:10.1111/obr.12366 · Cited by 118
Rapid improvement in diabetes after gastric bypass surgery
Lingvay, I., Guth, E., Islam, A., & Livingston, E. (2013) · Diabetes Care · doi:10.2337/dc12-2316 · Cited by 116
Predictors of type 2 diabetes remission in the Diabetes Remission Clinical Trial (DiRECT)
Thom, G., Messow, C. ‐., Leslie, W. S., Barnes, A. C., Brosnahan, N., McCombie, L., Al‐Mrabeh, A., Zhyzhneuskaya, S., Welsh, P., Sattar, N., et al. (2021) · Diabetic Medicine · doi:10.1111/dme.14395 · Cited by 113 · cited 2×
“However, surprisingly, post-hoc analysis of the original full DiRECT cohort found that weight loss, not T2D duration, was the strongest predictor of T2D remission [53].”
BackgroundLips, M. A., de Groot, G. H., van Klinken, J. B., Aarts, E., Berends, F. J., Janssen, I. M., Van Ramshorst, B., Van Wagensveld, B. A., Swank, D. J., Van Dielen, F., et al. (2014) · Clinical Endocrinology · doi:10.1111/cen.12254 · Cited by 99
15. Diabetes Advocacy: Standards of Medical Care in Diabetes—2018
American Diabetes Association (2018) · Diabetes Care · doi:10.2337/dc18-s015 · Cited by 97
Terranova, C. O., Brakenridge, C. L., Lawler, S. P., Eakin, E. G., & Reeves, M. M. (2015) · Diabetes, Obesity and Metabolism · doi:10.1111/dom.12430 · Cited by 94 · cited 1×
“Weight loss is the primary approach for nutritional management of T2D [6,7], and evidence shows that, compared to standard care, intensive multicomponent lifestyle interventions, including behavior change, physical activity and dietary energy restriction produce superior weight loss and improvement to glycemic control…”
BackgroundObesity, Orthopaedics, and Outcomes
Mihalko, W. M., Bergin, P. F., Kelly, F. B., & Canale, S. T. (2014) · Journal of the American Academy of Orthopaedic Surgeons · doi:10.5435/jaaos-22-11-683 · Cited by 81 · cited 1×
“justified rapid weight loss, such as prior to orthopedic surgery or organ transplant [30,71].”
BackgroundSteven, S., Hollingsworth, K. G., Small, P. K., Woodcock, S. A., Pucci, A., Aribasala, B., Al‐Mrabeh, A., Batterham, R. L., & Taylor, R. (2016) · Diabetic Medicine · doi:10.1111/dme.13257 · Cited by 71
By-Band-Sleeve Trial Management Group, Doble, B., Wordsworth, S., Rogers, C. A., Welbourn, R., Byrne, J., & Blazeby, J. M. (2017) · Obesity Surgery · doi:10.1007/s11695-017-2749-8 · Cited by 71
Effect of a low-calorie diet on restoration of normoglycemia in obese subjects with type 2 diabetes
Unnikrishnan, A., Bhatt, A., Choudhari, P., Mahajan, R., Sayyad, M., Pratyush, D., Hasan, I., Javherani, R., Bothale, M., & Purandare, V. (2017) · Indian Journal of Endocrinology and Metabolism · doi:10.4103/ijem.ijem_206_17 · Cited by 61
Reversal of type 2 diabetes in youth who adhere to a very-low-energy diet: a pilot study
Gow, M. L., Baur, L. A., Johnson, N. A., Cowell, C. T., & Garnett, S. P. (2016) · Diabetologia · doi:10.1007/s00125-016-4163-5 · Cited by 59 · cited 1×
“The recent endorsement by the American Diabetes Association for short-term usage of VLCDs for improving glycemic control is noteworthy [7], and evidence that VLCD is effective in reversing T2D in adolescents [73], suggests that more medical bodies may reconsider their positions on the use of VLCD in the treatment of T…”
BackgroundPreoperative Beta Cell Function Is Predictive of Diabetes Remission After Bariatric Surgery
Souteiro, P., Belo, S., Neves, J. S., Magalhães, D. M. D. S., Silva, R. B., Oliveira, S. C., Costa, M. M., Saavedra, A., Oliveira, J., Cunha, F. M., et al. (2016) · Obesity Surgery · doi:10.1007/s11695-016-2300-3 · Cited by 57
Sathananthan, M., Shah, M., Edens, K., Grothe, K. B., Piccinini, F., Farrugia, L. P., Micheletto, F., Man, C. D., Cobelli, C., Rizza, R. A., et al. (2015) · Journal of Nutrition · doi:10.3945/jn.115.210617 · Cited by 54
Cholelithiasis in patients treated with a very-low-calorie diet
Kamrath, R., Plummer, L., Sadur, C., Adler, M., Strader, W., Young, R., & Weinstein, R. (1992) · The American Journal of Clinical Nutrition · doi:10.1093/ajcn/56.1.255s · Cited by 47 · cited 1×
“Nevertheless, due to cost, and questions of long-term efficacy and potential health risks, including fatigue, diarrhea, and gall stones [30,34,35], VLCD approaches remain outside of standards of clinical care for the treatment of obesity and T2D [31].”
BackgroundLips, M. A., van Klinken, J. B., Pijl, H., Janssen, I. M. C., van Dijk, K. W., Koning, F., & van Harmelen, V. (2016) · Metabolism · doi:10.1016/j.metabol.2016.07.013 · Cited by 46 · cited 3×
“That study showed that after 3 months, FPG, HbA1c and HOMA-IR were similarly reduced by VLCD and RYGB, though weight loss was superior with RYGB [65].”
BackgroundInfluentialVery-low-energy diets and morbidity: a systematic review of longer-term evidence
Mulholland, Y., Nicokavoura, E., Broom, J., & Rolland, C. (2012) · British Journal of Nutrition · doi:10.1017/s0007114512001924 · Cited by 44
Umphonsathien, M., Prutanopajai, P., Aiam‐O‐Ran, J., Thararoop, T., Karin, A., Kanjanapha, C., Jiamjarasrangsi, W., & Khovidhunkit, W. (2019) · Food Science & Nutrition · doi:10.1002/fsn3.956 · Cited by 44 · cited 3×
“Dietary compliance was reported at 90%, and they reported that at weeks 4, 8 and 12 of the re-feeding phase, approximately 40%, 75% and 70% of subjects were in T2D remission, respectively [24].”
BackgroundInfluentialDefining remission of type 2 diabetes in research studies: A systematic scoping review
Captieux, M., Prigge, R., Wild, S., & Guthrie, B. (2020) · PLOS Medicine · doi:10.1371/journal.pmed.1003396 · Cited by 43 · cited 1×
“” A recent meta-analyis shows that the large degree of heterogeneity in how T2D remission is defined remains a major barrier to arriving at consensus on the efficacy of VLCD and T2D remission [41].”
BackgroundSarathi, V., Kolly, A., Chaithanya, H., & Dwarakanath, C. (2017) · Journal of Natural Science, Biology and Medicine · doi:10.4103/0976-9668.198343 · Cited by 39 · cited 1×
“[51] sought to examine T2D remission, but with more moderate calorie restriction of 1500 kcal/day than those typical of VLCD.”
MethodThom, G., McIntosh, A., Messow, C., Leslie, W. S., Barnes, A. C., Brosnahan, N., McCombie, L., Malkova, D., Al-Mrabeh, A., Zhyzhneuskaya, S. V., et al. (2020) · Diabetes Obesity and Metabolism · doi:10.1111/dom.14274 · Cited by 37 · cited 1×
“A recent study reported that higher levels of the orexigenic hormone ghrelin during the liquid diet phase of VLCD is a predictor of weight regain [58], suggesting that preenrollment ghrelin levels may be an effective screening tool.”
BackgroundReview: low caloric intake and gall‐bladder motor function
Festi, D., Colecchia, A., Larocca, A., Villanova, N., Mazzella, G., Petroni, M. L., Romano, F., & Roda, E. (2000) · Alimentary Pharmacology & Therapeutics · doi:10.1046/j.1365-2036.2000.014s2051.x · Cited by 36 · cited 1×
“Nevertheless, due to cost, and questions of long-term efficacy and potential health risks, including fatigue, diarrhea, and gall stones [30,34,35], VLCD approaches remain outside of standards of clinical care for the treatment of obesity and T2D [31].”
BackgroundBrown, A. C., Gouldstone, A., Fox, E., Field, A., Todd, W., Shakher, J., Bellary, S., Teh, M. M., Azam, M., John, R., et al. (2015) · BMJ Open · doi:10.1136/bmjopen-2014-007217 · Cited by 33 · cited 3×
“Subjects in the VLCD arm also received behavioral support using a multi-component approach called the Specialist Lifestyle Management (SLiM) weight loss program, that was reported to be successful in facilitating weight loss in obesity [29].”
BackgroundMethodResultXin, Y., Davies, A., McCombie, L., Briggs, A., Messow, C.-M., Grieve, E., Leslie, W. S., Taylor, R., & Lean, M. E. J. (2019) · The Lancet Diabetes & Endocrinology · doi:10.1016/s2213-8587(18)30346-2 · Cited by 32 · cited 10×
“CounterweightPlus weight management program [28].”
BackgroundMethodResultInfluentialYan, W., Bai, R., Yan, M., & Song, M. (2017) · Journal of Investigative Surgery · doi:10.1080/08941939.2016.1259375 · Cited by 31
Vezina, W. C., Grace, D., Hutton, L. C., Alfieri, M. H., Colby, P. R., Downey, D. B., Vanderwerf, R. J., White, N. F., & Ward, R. P. (1998) · Digestive Diseases and Sciences · doi:10.1023/a:1018863108262 · Cited by 17
Ugi, S., Morino, K., Yamaguchi, T., Yamamoto, H., Kaida, S., Miyazawa, I., Sato, D., Sekine, O., Fujita, Y., Kashiwagi, A., et al. (2019) · Endocrine Journal · doi:10.1507/endocrj.ej19-0054 · Cited by 7
Obesity: Overview of Treatments and Interventions
SEAGLE, H. M., WYATT, H., & Hill, J. O. (2001) · Elsevier eBooks · doi:10.1016/b978-012193155-1/50033-7 · Cited by 7
Cited by
Bays, H. E., Kirkpatrick, C. F., Maki, K. C., Toth, P. P., Morgan, R. T., Tondt, J., Christensen, S. M., Dixon, D. L., & Jacobson, T. A. (2024) · Journal of Clinical Lipidology · doi:10.1016/j.jacl.2024.04.001 · Cited by 166
Visceral Adipose Tissue: The Hidden Culprit for Type 2 Diabetes
Dhokte, S., & Czaja, K. (2024) · Nutrients · doi:10.3390/nu16071015 · Cited by 133
“Using this connection, researchers have discovered that calorie-deficit diets may be able to control the disease and, in some cases, even put it into remission [33].”
BackgroundInfluentialBays, H. E., Kirkpatrick, C. F., Maki, K. C., Toth, P. P., Morgan, R. T., Tondt, J., Christensen, S. M., Dixon, D. L., & Jacobson, T. A. (2024) · Obesity Pillars · doi:10.1016/j.obpill.2024.100108 · Cited by 126
“…and the substantial rate of remission of diabetes mellitus and hypertension that directly correlates to the amount of post operative weight reduction [24,202,246 – 248], with a directionally similar need to adjust anti-diabetes and antihypertension medications with very low-calorie diets [249,250].”
BackgroundThe Role of Glutathione and Its Precursors in Type 2 Diabetes
Tuell, D. S., Ford, G., LOS, E. A., & Stone, W. L. (2024) · Antioxidants · doi:10.3390/antiox13020184 · Cited by 43
Janssen, T. A. H., Van Every, D. W., & Phillips, S. M. (2023) · Current Opinion in Clinical Nutrition & Metabolic Care · doi:10.1097/mco.0000000000000980 · Cited by 33
“A popular form of VLCD is a very low-calorie ketogenic diet (VLCKD), && VLCKD on glycemic control, body weight, lipid profile, medication use, and dropouts vs. other recommended diets for 12 weeks or longer in people (cid:1) (cid:1) with T2D [43 ].”
BackgroundInfluential
Metadata
- Authors
- Juray, S., Axen, K. V., & Trasino, S. E.
- Affiliations
- Mount Sinai Hospital (US)
- City University of New York (US)
- Corresponding author
- Trasino, Steven E.
- ORCID
- Trasino, Steven E.
- Venue
- Nutrients
- Publisher
- MDPI AG
- Published
- 2021-06-18
- Volume
- 13
- Issue
- 6
- Pages
- 2086
- ISSN
- 2072-6643 (ISSN-L)
- PMC
- PMC8234895
- OpenAlex
- W3175270726
- Cited by
- 45
- References
- 80
- Citations by year
- 2026: 8 · 2025: 8 · 2024: 14 · 2023: 6 · 2022: 7 · 2021: 2
- FWCI
- 0.97
- Type
- journal article
- Language
- en
- Open access
- gold
- doi.org
- Licence
- Locations
- Nutrients (publishedVersion, cc-by)
- PubMed Central (publishedVersion, cc-by)
- PubMed (publishedVersion)
- CUNY Academic Works (City University of New York) (submittedVersion, cc-by)
- DOAJ (DOAJ: Directory of Open Access Journals) (submittedVersion, cc-by-sa)
- Topics
- Health Sciences › Medicine › Physiology (medical) › Diet and metabolism studies
- Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Diabetes Treatment and Management
- Health Sciences › Medicine › Physiology (medical) › Dietary Effects on Health
- Keywords
- type 2 diabetes remission, very low calorie diet, hypocaloric diet, weight loss, glycemic control
- MeSH terms
- Body Weight, Energy Intake, Diabetes Mellitus, Type 2, Humans, Obesity, Weight Loss, Caloric Restriction, Glycemic Index
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.